BoNT/A Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BoNT/A monoclonal antibodies for research focused on understanding the biological functions and mechanisms of botulinum neurotoxin type A. BoNT/A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Botulinum neurotoxin type A is a potent neurotoxin produced by the bacterium Clostridium botulinum, known for its ability to inhibit neurotransmitter release at the neuromuscular junction, leading to muscle paralysis. BoNT/A has significant applications in clinical settings, such as treating muscle spasticity and cosmetic procedures, while serving as a valuable tool in research to study synaptic transmission and neurobiology. Understanding BoNT/A mechanisms is crucial for developing therapeutic strategies and advancing knowledge in neurotoxicology. Researchers can utilize BoNT/A monoclonal antibodies to investigate molecular pathways and cellular responses in various experimental models. The specificity and reliability of BoNT/A monoclonal antibodies enable precise detection and analysis of target molecules across different research applications. Santa Cruz Biotechnology monoclonal antibodies for BoNT/A research support scientists worldwide in advancing neuroscience discoveries and therapeutic developments.